Royal DSM NV (DSM):企業の財務・戦略的SWOT分析

◆英語タイトル:Royal DSM NV (DSM) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDCH28932FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:70
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:Chemicals
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Royal DSM NV (DSM) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Royal DSM NV (DSM) is a science-based company with focus on materials, health and nutrition. It produces vitamins, carotenoids, nutritional lipids and other ingredients; specialty plastics; and fiber and resins solutions. The company develops materials for medical devices and clean energy from crop residues and bio-chemicals. DSM serves customers in animal nutrition and health, packaging and graphic arts, building and construction, pharma solutions, electrical and electronics, automotive, medical, personal care, energy, food, furniture, life protection, beverages and dietary supplements, marine, paint and coatings, sports, leisure and consumer goods, and textiles and clothing sectors. The company has operations across Eastern Europe, Latin America, North America, Asia, and other regions. DSM is headquartered in Heerlen, Limburg, the Netherlands.

Royal DSM NV Key Recent Developments

Mar 31,2021: DSM acquires Flavor & Fragrance bio-based intermediates business from Amyris
Mar 16,2021: DSM announces repurchase of shares to cover stock dividend
Mar 11,2021: DSM announces DSM Advanced Solar backsheets business to be acquired by Worthen Industries, Inc.
Mar 11,2021: DSM announces DSM Advanced Solar backsheets business to be acquired by Worthen Industries, Inc.
Mar 04,2021: DSM announces new supervisory board chairman and proposes new supervisory board member

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Royal DSM NV – Key Facts
Royal DSM NV – Key Employees
Royal DSM NV – Key Employee Biographies
Royal DSM NV – Major Products and Services
Royal DSM NV – History
Royal DSM NV – Company Statement
Royal DSM NV – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Royal DSM NV – Business Description
Business Segment: Corporate Activities
Performance
Business Segment: Innovation Center
Overview
Performance
Business Segment: Materials
Overview
Performance
Business Segment: Nutrition
Overview
Performance
Geographical Segment: China
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: North America
Performance
Geographical Segment: Rest of Asia
Performance
Geographical Segment: Rest of Europe
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: Switzerland
Performance
Geographical Segment: The Netherlands
Performance
R&D Overview
Royal DSM NV – Corporate Strategy
Royal DSM NV – SWOT Analysis
SWOT Analysis – Overview
Royal DSM NV – Strengths
Royal DSM NV – Weaknesses
Royal DSM NV – Opportunities
Royal DSM NV – Threats
Royal DSM NV – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances
Royal DSM NV, Petrochemicals, Deals By Year, 2015 to YTD 2021
Royal DSM NV, Petrochemicals, Deals By Type, 2015 to YTD 2021
Royal DSM NV, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 04, 2021: DSM announces new supervisory board chairman and proposes new supervisory board member
Feb 26, 2021: DSM announces price increase for polyamide 6 and 66 compounds in EMEA
Jan 20, 2021: DSM Nutritional Products’ President & CEO Chris Goppelsroeder to retire
Jan 05, 2021: DSM announces price increase for polyamides
Nov 27, 2020: Neste and DSM announce strategic partnership to create high performance materials made from sustainable feedstock
Nov 24, 2020: DSM Advanced Solar launches new all purpose Endurance backsheet
Nov 20, 2020: DSM announces global price increase for its polyamide 6 and 66 compounds and PBTs portfolio
Aug 04, 2020: DSM announces H1 2020 results
May 19, 2020: Open collaborative platform UNITE4COVID launched to accelerate Covid-19 solutions
May 07, 2020: DSM reports Q1 2020 results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Royal DSM NV, Key Facts
Royal DSM NV, Key Employees
Royal DSM NV, Key Employee Biographies
Royal DSM NV, Major Products and Services
Royal DSM NV, History
Royal DSM NV, Other Locations
Royal DSM NV, Subsidiaries
Royal DSM NV, Joint Venture
Royal DSM NV, Key Competitors
Royal DSM NV, Ratios based on current share price
Royal DSM NV, Annual Ratios
Royal DSM NV, Annual Ratios (Cont...1)
Royal DSM NV, Annual Ratios (Cont...2)
Royal DSM NV, Interim Ratios
Royal DSM NV, Petrochemicals, Deals By Year, 2015 to YTD 2021
Royal DSM NV, Petrochemicals, Deals By Type, 2015 to YTD 2021
Royal DSM NV, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Royal DSM NV (DSM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bechtel Corporation:企業の戦略的SWOT分析
    Bechtel Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Dairyland Power Cooperative:企業の発電所・SWOT分析2018
    Dairyland Power Cooperative - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key e …
  • Molecular Warehouse Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Molecular Warehouse Ltd (Molecular Warehouse) is a developer of proteins for diagnostic and therapeutic use. The company helps prevent diseases by empowering people with molecular diagnostics. Its synthetic biology techniques enabled it to reengineer glucose dehydrogenase, and enzymes found …
  • Kirby Corporation:戦略・SWOT・企業財務分析
    Kirby Corporation - Strategy, SWOT and Corporate Finance Report Summary Kirby Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Qorvo Inc (QRVO):企業の財務・戦略的SWOT分析
    Qorvo Inc (QRVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Byotrol Plc (BYOT):企業の財務・戦略的SWOT分析
    Summary Byotrol Plc (Byotrol) is a developer of residual antimicrobial technologies. The company offers multi pet surface disinfectant, advance moisture shampoo, advanced moisture, conditioning spray, advanced stain and odour, every day odour control spray, among others. It also identifies, develops …
  • British American Tobacco Plc (BATS):企業の財務・戦略的SWOT分析
    British American Tobacco Plc (BATS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Sangamo Therapeutics Inc (SGMO):製薬・医療:M&Aディール及び事業提携情報
    Summary Sangamo Therapeutics Inc (Sangamo), formerly Sangamo BioSciences Inc, is a clinical stage biotechnology company that focuses on the research, development and commercialization of engineered DNA-binding proteins (ZFPs) for gene regulation, cell therapy and therapeutic genome editing. Its prod …
  • K3 Business Technology Group plc (KBT):企業の財務・戦略的SWOT分析
    Summary K3 Business Technology Group plc (K3 BTG) is an information technology company that provides integrated business systems. The company offers products including axis fashion, fresh dynamics, MS dynamics AX, MS dynamics NAV, pebblestone fashion, sage, and syspro. Its services comprise CRM, ERP …
  • U.S. Bancorp:企業の戦略・SWOT・財務情報
    U.S. Bancorp - Strategy, SWOT and Corporate Finance Report Summary U.S. Bancorp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Ajinomoto Co Inc (2802)-製薬・医療分野:企業M&A・提携分析
    Summary Ajinomoto Co Inc (Ajinomoto) is a food products company that focuses on foods, bioscience fine chemicals and pharmaceuticals and health. It carries out research and development and production of seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. The …
  • Stanwell Corp Ltd:企業の戦略的SWOT分析
    Stanwell Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Genoptix Inc-製薬・医療分野:企業M&A・提携分析
    Summary Genoptix Inc (Genoptix) is a healthcare services provider that offers diagnostic solutions. The center offers oncology diagnostics and informatics services. It provides biopharma and healthcare laboratory, discovery, drug development, care and cost development; diagnostics, and patient servi …
  • IMI plc:企業の戦略・SWOT・財務分析
    IMI plc - Strategy, SWOT and Corporate Finance Report Summary IMI plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Glaukos Corp (GKOS):医療機器:M&Aディール及び事業提携情報
    Summary Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such …
  • Morepen Laboratories Ltd (MOREPENLAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Morepen Laboratories Ltd (Morepen Laboratories) is a manufacturer and supplier of active pharma ingredients and formulations. The company offers active pharma ingredients, formulation and homehealth solutions. It offers products in forms of tablets, capsules, liquids and powders. Morepen Lab …
  • Kelly Services Inc (KELYA):企業の財務・戦略的SWOT分析
    Kelly Services Inc (KELYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Monadelphous Group Ltd (MND):企業の財務・戦略的SWOT分析
    Monadelphous Group Ltd (MND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Companhia Energetica de Sao Paulo:発電所・企業SWOT分析
    Companhia Energetica de Sao Paulo - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Future Consumer Ltd (FCONSUMER):企業の財務・戦略的SWOT分析
    Future Consumer Ltd (FCONSUMER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆